Natick, MA, United States of America

Denise Karaoglu Hanzatian

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Abbvie Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denise Karaoglu Hanzatian. Retrieved from https://idiyas.com/inventor/denise-karaoglu-hanzatian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Denise Karaoglu Hanzatian

Introduction

Denise Karaoglu Hanzatian is an innovative inventor based in Natick, Massachusetts. She is known for her significant contributions to the field of biomedical research and has made notable advancements in the development of binding proteins.

Latest Patents

Denise holds a patent for "LRP-8 binding dual variable domain immunoglobulin proteins." This patent discloses binding proteins that are specifically designed to bind to LRP-8, with the potential to cross the blood-brain barrier (BBB). The invention aims to localize in the brain and/or spinal cord, offering promising avenues for medical therapies.

Career Highlights

Denise has made a name for herself at AbbVie Inc., where she has utilized her expertise to drive innovation in the biotechnology sector. Her focus on developing advanced binding proteins demonstrates her commitment to addressing critical health challenges.

Collaborations

Throughout her career, Denise has collaborated with skilled researchers and professionals, including Lorenzo Benatuil and Kangwen Deng. These partnerships highlight the importance of teamwork in advancing scientific discoveries and innovations.

Conclusion

Denise Karaoglu Hanzatian stands out as a remarkable inventor whose work is contributing to vital advancements in the biomedical field. Her patent on LRP-8 binding proteins signifies her dedication to improving medical outcomes and showcases her potential to continue making impactful innovations in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…